Skip to Main Content

Paper Details

Cyproheptadine displays preclinical activity in myeloma and leukemia.
Blood
41
2008
Cyproheptadine, D-cyclin, D-cyclins, H1, cancer, caspase, cyclin D2 promoter, cyclin-dependent kinases, cyclins D1, D2, and D3, cyproheptadine, hematologic malignancies, histamine, leukemia, malignancy, mouse, multiple myeloma, myeloma, myeloma and leukemia, myeloma and leukemia cell lines, myeloma and leukemia cells, normal hematopoietic cells, patient, serotonin, serotonin receptor, tumor, tumors

Datasets

Release 1.2